When.com Web Search

  1. Ads

    related to: color guard test for colon cancer

Search results

  1. Results From The WOW.Com Content Network
  2. Blood test for colon cancer screening is approved by US ...

    www.aol.com/lifestyle/blood-test-colon-cancer...

    U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths. Test manufacturer Guardant said the ...

  3. FDA approves new blood test to screen for colon cancer

    www.aol.com/news/fda-approves-blood-test-screen...

    Another colon cancer screening method includes fecal occult blood tests that detect blood in the stool, which can be a warning sign of colon polyps or cancer. The FIT-DNA tests, such as Cologuard ...

  4. New colorectal cancer blood test approved by FDA: What to know

    www.aol.com/colorectal-cancer-blood-test...

    The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.

  5. Guardant Health - Wikipedia

    en.wikipedia.org/wiki/Guardant_Health

    Guardant Health also launched a colon cancer detection test called Shield. [43] The company partnered with the Vall d'Hebron Institute of Oncology to launch the first blood-based cancer testing services in Barcelona in mid 2022. [44] Guardant Health also licensed cancer tests to the clinical laboratory company Adicon for research testing in China.

  6. Guardant's blood-based cancer test moves closer to Medicare ...

    www.aol.com/news/us-fda-approves-guardant-health...

    According to the FDA's documents, a study showed Guardant's Shield test detected 83% of colorectal cancers. Exact Sciences' stool test Cologuard had a 92.3% sensitivity rate.

  7. Exact Sciences Corp. - Wikipedia

    en.wikipedia.org/wiki/Exact_Sciences_Corp.

    Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.